Literature DB >> 1089710

E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells.

L Borella, L Sen.   

Abstract

The presence of receptors for sheep erythrocytes (E) and sufrace Ig on the bone marrow blasts was investigated in 29 children with untreated acute lymphocytic leukemia (ALL). In 6 of them more than 50% of the bone marrow blasts formed E rosettes, while in none of the 29 were surface Ig detected. The six children with rosette-forming blasts had WBS greater than 5 times 10-4/mm-3 at admission and 4 of them presented with thymic enlargement. E-positive ALL blasts and normal human thymocytes formed rosettes after incubation for 1 hr at 4 degrees C or 37 degrees C. In contrast, normal human peripheral T lymphocytes from blood, spleen, and pleural fluid also formed rosettes at 4 degrees C but these rosettes dissociated at 37 degrees C. In two patients with E-positive ALL, the disappearance from blood of cells forming rosettes at 37 degrees C during the 1st week of treatments paralleled the reduction in circulating blasts. Conversely, after 6 days of therapy almost one-half of the remaining cells formed rosettes at 4 degrees C and had the morphologic features of normal lymphocytes. We conclude that, in contrast to peripheral T cells, normal thymic cells and E-positive blasts share the property of forming E rosettes after 1-hr incubation at 37 degrees C. In patients with E-positive ALL this property may be used to evaluate drug effects upon leukemic and normal T lymphocytes.

Entities:  

Mesh:

Year:  1975        PMID: 1089710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Dynamics of T-lymphocyte subpopulations and T-lymphocyte function following thermal injury.

Authors:  G W Wood; F J Volenec; M M Mani; L J Humphrey
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

2.  Rosette formation with goat erythrocytes. A marker for human T lymphocytes.

Authors:  F Pandolfi; J T Kurnick; K Nilsson; K Forsbeck; H Wigzell
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

3.  Influence of thymosin on E-rosette formation of lymphoid cells in leukemic and nonleukemic children.

Authors:  H Winterleitner; W Rella; G Stingl; W Knapp
Journal:  Blut       Date:  1979-04-20

4.  [T-cell-antigen positive, E-rosette negative acute lymphoblastic leukaemia (author's transl)].

Authors:  E Thiel; H Rodt; D Netzel; D Huhn; G F Wündisch; R J Hass; C Bender-Götze; S Thierfelder
Journal:  Blut       Date:  1978-06-20

Review 5.  The T lymphoblastic malignancies.

Authors:  L M Nadler; E L Reinherz; S F Schlossman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

6.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

7.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

8.  Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.

Authors:  D M Knowles; J P Halper
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

9.  Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral blood.

Authors:  C F Bryan; S H Leech; R Ducos; C Q Edwards; J P Kushner; M H Skolnick; B Bozelka; J C Linn; R Gaumer
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

10.  Immunological distinction of adult T cell leukaemia from T cell acute lymphoblastic leukaemia.

Authors:  T Tsubota; I Miyoshi; J Uno; S Hiraki; T Kobayashi; U Sato; I Kimura
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.